332 related articles for article (PubMed ID: 24746976)
1. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.
Sánchez-Lara K; Turcott JG; Juárez-Hernández E; Nuñez-Valencia C; Villanueva G; Guevara P; De la Torre-Vallejo M; Mohar A; Arrieta O
Clin Nutr; 2014 Dec; 33(6):1017-23. PubMed ID: 24746976
[TBL] [Abstract][Full Text] [Related]
2. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
Read JA; Beale PJ; Volker DH; Smith N; Childs A; Clarke SJ
Support Care Cancer; 2007 Mar; 15(3):301-7. PubMed ID: 17021855
[TBL] [Abstract][Full Text] [Related]
3. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
[TBL] [Abstract][Full Text] [Related]
4. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.
Pappalardo G; Almeida A; Ravasco P
Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317
[TBL] [Abstract][Full Text] [Related]
5. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients].
Gómez-Candela C; Villarino Sanz M; Horrisberger A; Loria Kohen V; Bermejo LM; Zamora Auñón P
Nutr Hosp; 2011; 26(6):1385-93. PubMed ID: 22411387
[TBL] [Abstract][Full Text] [Related]
7. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
[TBL] [Abstract][Full Text] [Related]
8. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial.
Ryan AM; Reynolds JV; Healy L; Byrne M; Moore J; Brannelly N; McHugh A; McCormack D; Flood P
Ann Surg; 2009 Mar; 249(3):355-63. PubMed ID: 19247018
[TBL] [Abstract][Full Text] [Related]
9. Oral nutritional supplement fortified with beta-alanine improves physical working capacity in older adults: a randomized, placebo-controlled study.
McCormack WP; Stout JR; Emerson NS; Scanlon TC; Warren AM; Wells AJ; Gonzalez AM; Mangine GT; Robinson EH; Fragala MS; Hoffman JR
Exp Gerontol; 2013 Sep; 48(9):933-9. PubMed ID: 23832078
[TBL] [Abstract][Full Text] [Related]
10. Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease--a randomized controlled trial.
Norman K; Kirchner H; Freudenreich M; Ockenga J; Lochs H; Pirlich M
Clin Nutr; 2008 Feb; 27(1):48-56. PubMed ID: 17964008
[TBL] [Abstract][Full Text] [Related]
11. [A case of stage IV rectal cancer with whom EPA oral nutritional supplements could resolve cachectic condition and promote patient compliance with cancer chemotherapy].
Hamamura K; Nakaya M; Nakagawa M; Miyazaki M; Miki C
Gan To Kagaku Ryoho; 2011 May; 38(5):845-8. PubMed ID: 21566451
[TBL] [Abstract][Full Text] [Related]
12. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review.
Elia M; Van Bokhorst-de van der Schueren MA; Garvey J; Goedhart A; Lundholm K; Nitenberg G; Stratton RJ
Int J Oncol; 2006 Jan; 28(1):5-23. PubMed ID: 16327975
[TBL] [Abstract][Full Text] [Related]
13. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
Fearon KC; Von Meyenfeldt MF; Moses AG; Van Geenen R; Roy A; Gouma DJ; Giacosa A; Van Gossum A; Bauer J; Barber MD; Aaronson NK; Voss AC; Tisdale MJ
Gut; 2003 Oct; 52(10):1479-86. PubMed ID: 12970142
[TBL] [Abstract][Full Text] [Related]
14. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children.
Bayram I; Erbey F; Celik N; Nelson JL; Tanyeli A
Pediatr Blood Cancer; 2009 May; 52(5):571-4. PubMed ID: 19090549
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer.
Evans WK; Nixon DW; Daly JM; Ellenberg SS; Gardner L; Wolfe E; Shepherd FA; Feld R; Gralla R; Fine S
J Clin Oncol; 1987 Jan; 5(1):113-24. PubMed ID: 3027267
[TBL] [Abstract][Full Text] [Related]
16. Effects of a low-volume, nutrient- and energy-dense oral nutritional supplement on nutritional and functional status: a randomized, controlled trial in nursing home residents.
Stange I; Bartram M; Liao Y; Poeschl K; Kolpatzik S; Uter W; Sieber CC; Stehle P; Volkert D
J Am Med Dir Assoc; 2013 Aug; 14(8):628.e1-8. PubMed ID: 23810109
[TBL] [Abstract][Full Text] [Related]
17. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.
van der Meij BS; Langius JA; Smit EF; Spreeuwenberg MD; von Blomberg BM; Heijboer AC; Paul MA; van Leeuwen PA
J Nutr; 2010 Oct; 140(10):1774-80. PubMed ID: 20739445
[TBL] [Abstract][Full Text] [Related]
18. Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition.
Trabal J; Leyes P; Forga M; Maurel J
Nutr Hosp; 2010; 25(5):736-40. PubMed ID: 21336429
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery.
Sorensen LS; Thorlacius-Ussing O; Schmidt EB; Rasmussen HH; Lundbye-Christensen S; Calder PC; Lindorff-Larsen K
Br J Surg; 2014 Jan; 101(2):33-42. PubMed ID: 24281905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
